ONCY
Oncolytics Biotech Inc
NASDAQ: ONCY · HEALTHCARE · BIOTECHNOLOGY
$0.88
+1.03% today
Updated 2026-04-30
Market cap
$112.49M
P/E ratio
—
P/S ratio
58.60x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
1.1M
Oncolytics Biotech Inc (ONCY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.85M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $0.00 | $0.00 | $4.31M | $3.78M | $4.19M | $5.33M | $4.85M | $0.00 | $0.00 | $180411.00 | $162233.00 | $90768.00 | $95375.00 | $485574.00 | $332652.00 | $360575.00 | $301109.00 | $298587.00 | — | — |
| Gross profit | $0.00 | $0.00 | $-4.31M | $-3.78M | $-4.19M | $-5.33M | $0.00 | $0.00 | $0.00 | $-180411.00 | $-162233.00 | $-90768.00 | $-95375.00 | $-485574.00 | $-332652.00 | $-360575.00 | $-301109.00 | $-298587.00 | — | — |
| Gross margin | — | — | — | — | — | — | 0.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $10.54M | $11.32M | $13.35M | $12.15M | $12.19M | $23.39M | $31.40M | $18.51M | $13.82M | $8.60M | $9.77M | $9.39M | $9.42M | $11.13M | $9.65M | $10.31M | $11.85M | $13.12M | $21.65M | $13.31M |
| SG&A | $4.03M | $4.53M | $64039.00 | $4.40M | $3.25M | $1.14M | $730751.00 | $372744.00 | $5.00M | $5.14M | $5.36M | $6.21M | $7.24M | $9.56M | $12.51M | $13.31M | $11.49M | $16.08M | $13.34M | $15.41M |
| Operating income | $-15.50M | $-16.85M | $-18.07M | $-17.00M | $-20.04M | $-28.72M | $-36.69M | $-23.90M | $-18.82M | $-13.92M | $-15.29M | $-15.61M | $-16.66M | $-20.69M | $-18.98M | $-20.93M | $-20.68M | $-25.04M | $-34.98M | $-28.73M |
| Operating margin | — | — | — | — | — | — | -756.2% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-14.53M | $-15.83M | $-17.66M | $-16.75M | $-19.29M | $-27.93M | $-36.58M | $-23.77M | $-18.66M | $-13.74M | $-15.13M | $-15.51M | $-17.18M | $-19.66M | $-16.45M | $-20.58M | $-18.71M | $-20.19M | $-34.88M | $-28.73M |
| EBITDA margin | — | — | — | — | — | — | -754.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-15.46M | $-16.84M | $-18.07M | $-17.00M | $-19.35M | $-28.02M | $-36.69M | $-23.90M | $-18.82M | $-13.92M | $-15.29M | $-15.61M | $-17.27M | $-20.14M | $-16.78M | $-20.94M | $-19.01M | $-20.49M | $-34.98M | $-28.80M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $138426.00 | $528000.00 | — | — | — |
| Income tax | $-1.20M | $-1.20M | $0.00 | $23036.00 | $7611.00 | $40000.00 | $30474.00 | $5408.00 | $6779.00 | $3153.00 | $9374.00 | $141498.00 | $548042.00 | $12.43M | $-2.95M | $39423.00 | $64523.00 | $71868.00 | $130000.00 | — |
| Effective tax rate | 7.7% | 7.1% | 0.0% | -0.1% | -0.0% | -0.1% | -0.1% | -0.0% | -0.0% | -0.0% | -0.1% | -0.9% | -3.3% | -37.5% | 15.0% | -0.2% | -0.3% | -0.4% | -0.4% | 0.0% |
| Net income | $-14.30M | $-15.64M | $-17.55M | $-17.00M | $-19.97M | $-29.04M | $-36.37M | $-23.53M | $-18.62M | $-13.72M | $-15.14M | $-15.62M | $-17.04M | $-45.55M | $-16.78M | $-20.98M | $-19.08M | $-20.56M | $-31.71M | $-28.76M |
| Net income growth (YoY) | — | -9.4% | -12.2% | +3.2% | -17.5% | -45.4% | -25.2% | +35.3% | +20.9% | +26.3% | -10.3% | -3.1% | -9.1% | -167.4% | +63.2% | -25.0% | +9.1% | -7.8% | -54.2% | +9.3% |
| Profit margin | — | — | — | — | — | — | -749.7% | — | — | — | — | — | — | — | — | — | — | — | — | — |